Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Carol A. Pollock"'
Autor:
Rosy Wang, Benjamin P. Larkin, Hui Chen, Sonia Saad, Miao Hou, Carol A. Pollock, Long T. Nguyen, Sarah J. Glastras
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
BackgroundMaternal obesity is a risk factor for chronic kidney disease (CKD) in offspring, underpinning the theory of the developmental origins of health and disease. DNA methylation has been implicated in the programming of adult chronic disease by
Autor:
Ji Hu, Kris Rogers, Ying Xie, Carinna Hockham, Meg Jardine, David Peiris, Sophia Zoungas, Tamara Young, Anna Campain, Louisa Sukkar, Jannah Baker, Alan Cass, Carol A. Pollock, Amy Kang, Min Jun, Germaine Wong
Publikováno v:
Diabetes Care. 43:e185-e187
Stepwise escalation of glucose-lowering therapy to more intensive regimens is an integral component of type 2 diabetes management (1). Early blood glucose control is associated with beneficial effects on long-term micro- and macrovascular outcomes (2
Autor:
Carol A. Pollock, Aisha Chow, Gail Walkenshaw, David Gervasi, Lynda A. Szczech, Simon D. Roger
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor approved in China and Japan for the treatment of anemia in patients with chronic kidney disease (CKD). In Phase 3 clinical studies, roxadustat wa
Autor:
Roberto Pecoits Filho, Eric Wittbrodt, Andrew Briggs, Csaba P. Kovesdy, Mario Ouwens, Navdeep Tangri, Bartholomeus Willigers, Oliver Darlington, Marvin Sinsakul, Juan Jose Garcia Sanchez, Carol A. Pollock, Purav Bhatt, David C. Wheeler, Hiddo J.L. Heerspink
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Elevated albuminuria in patients with chronic kidney disease (CKD) is associated with increased risks of CKD progression, cardiovascular events and all-cause death. In the DAPA-CKD study, dapagliflozin significantly reduced the ri
Autor:
Benjamin P. Larkin, Rosy Wang, Miao Hou, Long T. Nguyen, Sonia Saad, Hui Chen, Carol A. Pollock, Sarah J. Glastras
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248854 (2021)
PLoS ONE
PLoS ONE
Background Maternal high fat diet (HFD) promotes chronic kidney disease (CKD) in offspring. This is in accordance with the theory of fetal programming, which suggests adverse conditions occurring in utero predispose offspring to chronic conditions la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e18bf900265dfba64336caadbc7034b
https://hdl.handle.net/10453/152976
https://hdl.handle.net/10453/152976
Autor:
David C. Wheeler, Peter Rossing, Bergur V. Stefánsson, Hiddo J.L. Heerspink, Carol A. Pollock, Daniel Reyner, Anna Maria Langkilde, C. David Sjöström
Publikováno v:
Pollock, C, Stefánsson, B, Reyner, D, Rossing, P, Sjöström, C D, Wheeler, D C, Langkilde, A M & Heerspink, H J L 2019, ' Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT) : a randomised, double-blind, placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 6, pp. 429-441 . https://doi.org/10.1016/S2213-8587(19)30086-5
Lancet Diabetes & Endocrinology, 7(6), 429-441. ELSEVIER SCIENCE INC
Lancet Diabetes & Endocrinology, 7(6), 429-441. ELSEVIER SCIENCE INC
Background: In patients with type 2 diabetes, intensive glucose control can be renoprotective and albuminuria-lowering treatments can slow the deterioration of kidney function. We assessed the albuminuria-lowering effect of the sodium-glucose co-tran
Autor:
Stephen Harrap, Meg Jardine, Muh Geot Wong, Takashi Wada, Megumi Oshima, Akinori Hara, Min Jun, Vlado Perkovic, Mark Woodward, Neil R Poulter, Carol A. Pollock, John Chalmers, Tadashi Toyama, Mark E. Cooper
Publikováno v:
Kidney International Reports, Vol 6, Iss 2, Pp 284-295 (2021)
Kidney International Reports
Kidney International Reports
Introduction Several circulating markers, including autoantibodies to erythropoietin receptor (anti-EPOR antibodies), have been identified as useful biomarkers in predicting diabetic kidney disease progression. However, a direct comparison of their u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9294db0dd9a8e8bab3109a21641771
http://hdl.handle.net/10044/1/90475
http://hdl.handle.net/10044/1/90475
Autor:
Usha Panchapakesan, Carol A. Pollock
Publikováno v:
Nature Reviews Nephrology. 17:223-224
Recent clinical trials demonstrated that sodium–glucose co-transporter 2 inhibitors can reduce hospitalization for heart failure and improve hard kidney end points in patients with and without type 2 diabetes mellitus. These observations consolidat
Publikováno v:
Transplantation proceedings. 52(1)
Background We present a first case of orthostatic renal graft compression and acute kidney injury following weight gain. Case Report A 61-year-old male with a second cadaveric transplant presented with acute kidney injury - creatinine rise from 80 to
Autor:
Yeoungjee Cho, Muh Geot Wong, David W. Johnson, Bruce A. Cooper, Nicole M. Isbel, Elaine M. Pascoe, Carolyn van Eps, Scott B. Campbell, Carmel M. Hawley, David Harris, Andrea K. Viecelli, Isabelle Ethier, Carol A. Pollock
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0242254 (2020)
PLoS ONE, Vol 15, Iss 11, p e0242254 (2020)
BackgroundResidual kidney function (RKF) is associated with improved survival and quality of life in dialysis patients. Previous studies have suggested that initiation of peritoneal dialysis (PD) may slow RKF decline compared to the pre-dialysis peri